Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China

International Journal of Cancer

Volumn 120, Issue 9, 2007, Pages 1981-1985

  Hsing, Ann W ^a   Gao, Yu Tang ^b   McGlynn, Katherine A ^a   Niwa, Shelley ^c   Zhang, Mingdong ^a,d   Han, Tian Quan ^e   Wang, Bing Sheng ^f   Chen, Jinbo ^a,g   Sakoda, Lori C ^a   Shen, Ming Chang ^h   Zhang, Bai He ⁱ   Deng, Jie ^b   Rashid, Asif ^j  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c WESTAT   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^f ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^g University School of Medicine   (United States)

^h Shanghai Tumor Hospital   (China)

ⁱ Second Military University   (China)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

Biliary tract cancer; China; Family history; Family history of liver cancer; Liver cirrhosis; Viral hepatitis

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILE DUCT STONE; BILIARY TRACT CANCER; CANCER RISK; CHINA; CHOLANGITIS; CHOLELITHIASIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GALLSTONE; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RARE DISEASE; RISK FACTOR; SEROLOGY; VATER PAPILLA; VIRUS HEPATITIS;

EID: 33947225759     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22375     Document Type: Article

References (47)

1. Hsing AW, Rashid A, Devesa SS, Fraumeni JF, Jr. Biliary tract cancer. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer epidemiology and prevention. Oxford: Oxford University Press, 2006. 787-800.
2. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G, Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-64.
3. Hsing AW, Gao Y-T, Devesa SS, Jin F Fraumeni JF, Jr. Rising incidence of biliary tract cancer in Shanghai, China, 1972-1992. Int J Cancer 1998;73:368-70.
4. Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, Polansky M, Berlin JA. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995;76:1747-56.
5. De Groen PC, Geores GJ, LaRusso NF. Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368-78.
6. Ghadirian P, Simard A, Baillargeon J. A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada. Rev Epidemiol Sante Publique 1993;41:107-12.
7. Khan ZR, Neugut AI, Ahsan H, Chabot JA. Risk factors for biliary tract cancers. Am J Gastroenterol 1999;94:149-52.
8. Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999;10:5308-5311.
9. Nath G, Singh H, Shukla VK. Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev 1997;6:557-9.
10. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, Sithithaworn P, Elkins DB. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 1994;59:505-9.
11. Kuper H, Ye W, Broome U, Romelsjo A, Mucci LA, Ekbom A, Adami HO, Trichopoulos D, Nyren O. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 2001;34:714-18.
12. Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000;95:784-7.
13. Shukla VK, Singh H, Pandey M, Upadhyay SK, Nath G. Carcinoma of the gallbladder-is it a sequel of typhoid? Dig Dis Sci 2000;45: 900-3.
14. Chen R, Zou S, Zhao X. The expression of hepatitis C virus in hilar cholangiocarcinoma and implication. Chin J Exp Surg 2000;17: 223-5.
15. Yin F, Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J 1998;111:1068-70.
16. Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998;4:392-6.
17. Liu E, Sakoda LC, Gao Y-T, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BE, Fraumeni JF, Jr, Hsing AW. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2005;14:1315-18.
18. Ueki T, Hsing AW, Gao YT, Wang BS, Shen MC, Cheng J, Deng J, Fraumeni JF, Jr, Rashid A. Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. Clin Cancer Res 2004;10:1717-25.
19. Wang BS, Qin J, Deng J, Zhang BH, Han TQ, Shen MC, Rashid A, Hsing AW, Gao YT. A survey on the diagnosis and treatment of biliary tract cancers in Shanghai. Zhonghua Wai Ke Za Zhi 2005;43:455-9.
20. Hou L, Xu J, Gao YT, Rashid A, Zhang L, Sakoda LC, Sheng MC, Wang BS, Deng J, Han TQ, Zhang BE, Meyers D, et al. CYP17 MspA1 polymorphism and the risk of biliary tract cancer and stones: a population-based study in Shanghai, China. Int J Cancer 2005;118: 2847-53.
21. Zhang X, Andreotti G, Gao YT, Deng J, Liu EJ, Rashid A, Wu K, Sun L, Sakoda L, Cheng J, Sheng MC, Wang BS, et al. Tea consumption and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Int J Cancer 2006;118: 3089-94.
22. Sakoda LC, Gao YT, Rashid A, Chen BE, Chen J, Rosenberg P, Deng J, Shen MC, Wang BS, Han TQ, Zhang BE, Webb HC, et al. Prostaglandin synthase 2 gene polymorphisms and risk of biliary tract cancer: a population-based study in Shanghai. China. Carcinogenesis 2006;27: 1251-6.
23. Breslow NE, Day NE. Statistical methods in cancer research, vol. 1: The analysis of case-control studies. Lyon, France: IARC, 1980.
24. Acalovschi M, Dumitrascu DL, Nicoara CD. Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones. Dig Dis Sci 2004;49:17-24.
25. Acalovschi M, Blendea D, Feier C, Letia AI, Ratiu N, Dumitrascu DL, Veres A. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study. Am J Gastroenterol 2003;98: 1856-60.
26. Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med 1999;159:49-52.
27. Maggi A, Solenghi D, Panzeri A, Borroni G, Cazzaniga M, Sangiovanni A, De Fazio C, Salerno F. Prevalence and incidence of cholelithiasis in patients with liver cirrhosis. Ital J Gastroenterol Hepatol 1997; 29:330-5.
28. Del Olmo JA, Garcia F, Serra MA, Maldonado L, Rodrigo JM. Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol 1997;32:1061-5.
29. Buchner AM, Sonnenberg A. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. Am J Gastroenterol 2002;97:905-9.
30. Grassi M, Allevato C, Mammucari S, Lazzari S, Nocchi S. The prevalence of gallstones in patients suffering from liver cirrhosis: a clinico-statistical study of 350 patients. Ital J Gastroenterol 1992; 24:342-6.
31. Li CP, Hwang SJ, Lee FY, Chang FY, Lin HC, Lu RH, Chu CJ, Lee SD. Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. Dig Dis Sci 2000;45:1109-14.
32. Yuan JM, Govindarajan S, Henderson BE, Yu MC. Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China. Br J Cancer 1996;74:491-3.
33. Zhao S, Xu Z, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol 2000;29:744-52.
34. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000;14:703-9.
35. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-5.
36. Sceuer PJ. Viral hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the liver, 3rd edn. Hong Kong: Churchill Livingstone, 1994. 243-68.
37. Yu SZ, Zi XL, Chen G. The relationship between viral hepatitis and primary liver cancer in four areas of China. Zhonghau Liu Xing Bing Xue Zazhi 1997;18:214-16.
38. Acalovschi M. Cholangiocarcinoma: risk factors, diagnosis and management. Rom J Intern Med 2004;42:41-58.
39. Jung YS, Lee KJ, Kim H, Kim WH, Kim IG, Yoo BM, Kim JH, Kim MW. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union. Hepatogastroenterology 2004;51: 946-9.
40. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004;99:523-6.
41. Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Jr, Gao YT. Cancer incidence trends in urban Shanghai, 1972-1994: an update. Int J Cancer 1999;83:435-40.
42. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
43. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15:1356-61.
44. Maddrey WC. Hepatitis B- an important public health issue. Clin Lab 2001;47:51-5.
45. Ito S, Yao DF, Nu C, Hibino S, Kamamura M, Nisikado T, Honda H, Shimizu I, Meng XY. Epidemiological characteristics of the incidence of hepatitis C virus (C 100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1993;8:232-7.
46. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75: 347-54.
47. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14-18.